ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 438 out of 2343

$542K Total Retail Price of All Prescriptions

Rank: 581 out of 2343

228 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 228 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 228 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 9,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 395 362 1 5
ZOLPIDEM TARTRATE 377 347 2 24
SIMVASTATIN 353 300 3 1
OMEPRAZOLE 305 232 4 4
METOPROLOL TARTRATE 297 280 5 7
FUROSEMIDE 277 257 6 6
LISINOPRIL 256 215 7 3
DIOVAN 254 221 8 23
MECLIZINE HCL 234 227 9 103
ISOSORBIDE MONONITRATE ER 217 197 10 32
FLUTICASONE PROPIONATE 194 169 11 46
IBUPROFEN 190 157 12 75
METFORMIN HCL 177 149 13 9
LOVAZA 168 163 14 113
RANITIDINE HCL 162 157 15 43
SYNTHROID 157 144 16 40
LEVOTHYROXINE SODIUM 154 135 17 2
NEXIUM 153 153 18 33
ATENOLOL 142 126 19 12
CELEBREX 129 124 20 71
POTASSIUM CHLORIDE 119 98 21 18
DIOVAN HCT 113 94 22 63
PROAIR HFA 108 75 23 86
LOVASTATIN 105 94 24 47
PLAVIX 100 100 25 38
ADVAIR DISKUS 97 83 26 34
GLIPIZIDE 95 79 27 56
WARFARIN SODIUM 94 71 28 8
DICYCLOMINE HCL 93 83 29 202
TRIAMTERENE-HCTZ 92 81 30 57
ZETIA 92 92 30 52
LIDODERM 92 79 30 130
VENTOLIN HFA 91 80 33 79
PROCTOZONE-HC 90 74 34 208
GLYBURIDE 87 87 R 35 62
FLUOXETINE HCL 80 72 36 82
CLOPIDOGREL 79 79 37 26
ALENDRONATE SODIUM 76 65 38 28
ESCITALOPRAM OXALATE 76 76 38 55
VOLTAREN 75 61 40 175
GABAPENTIN 73 60 41 16
LEXAPRO 73 73 41 178
ATORVASTATIN CALCIUM 71 71 43 10
CYCLOBENZAPRINE HCL 68 51 R 44 109
GLYBURIDE-METFORMIN HCL 68 68 R 44 154
JANUVIA 68 58 44 50
TEKTURNA 68 62 44 326
NITROSTAT 68 68 44 164
ALLOPURINOL 67 55 49 31
COUMADIN 67 58 49 216
DONEPEZIL HCL 66 66 51 21
CILOSTAZOL 65 65 52 204
HYDROCHLOROTHIAZIDE 64 60 53 11
METOPROLOL SUCCINATE 63 50 54 14
ACTOS 61 55 55 125
CARVEDILOL 61 48 55 27
CHLORHEXIDINE GLUCONATE 60 57 57 219
SINGLE USE SWAB 60 59 57 241
TAMSULOSIN HCL 59 59 59 29
AZITHROMYCIN 52 46 60 39
LIPITOR 50 50 61 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.